INTRODUCTION
Recurrent thrombocytopenia with microangiopathic hemolysis presenting in early childhood is believed to be a hereditary form of thrombotic thrombocytopenic purpura (TTP). Clinical manifestations are similar to the more common adult form. Both improve upon plasma transfusion 1, 2 and are characterized by the presence of ultra large multimers of von Willebrand factor (vWF). 3 The diagnosis of TTP in patients who do not present with all the features of TTP is particularly problematic. Clinical distinctions among TTP, genetic factor H deficiency, 4 and the hemolytic uremic syndrome are not always apparent.
Recent studies demonstrate that deficiency of a plasma metalloprotease activity, ADAMTS13, causes TTP. 5 In the adult-onset, acquired form of the disease, autoimmune inhibitors cause the deficiency. 6 -8 In the congenital or hereditary cases, mutations of ADAMTS13 are detected. 5 In the circulation, vWF is unfolded by high levels of shear stress as encountered in the arterioles and capillaries. 9 The unfolded forms of vWF are more likely to bind platelets. 8, 10 ADAMTS13 is believed to prevent platelet aggregation in normal circulation by cleaving the unfolded vWF. Patients with a severe deficiency of ADAMTS13 activity accumulate unfolded forms of vWF in the circulation, leading to vWF-platelet binding and the formation of platelet thrombi in the arterioles and capillaries, characteristic of TTP. 11 In this manuscript, we present the case of a female infant who was suspected of having TTP on her first day of life.
CASE REPORT
A full-term female infant was vaginally delivered at a community hospital 3 hours after spontaneous rupture of membranes. Pregnancy and labor were uncomplicated and the infant weighed 3.87 kg (>90%). Family history was significant for two siblings with neonatal jaundice and anemia. The first born did not receive any treatment. The second child remained hospitalized for a 7-day course of antibiotics for suspected sepsis. This sibling also was thrombocytopenic, but did not require any transfusions.
At 4 hours of life, the patient was febrile, cyanotic, and tachypneic, and required supplemental oxygen. Dark tea-colored urine was also observed. Both maternal and infant blood types were A-positive and the Coombs test was negative. Initial laboratories revealed hematocrit of 50%, platelet count of 84Â10 9 /l, and white blood cell count of 30Â10 9 /l. The patient was then transferred to the Neonatal Intensive Care Unit at Children's Hospital Medical Center for further evaluation.
The physical exam showed a jaundiced, afebrile, and normotensive infant. She had a grade III/VI systolic ejection murmur; there was normal liver and spleen size. Ultrasound examination detected small bilateral pleural effusions, no evidence of masses or renal vein thrombosis, and a structurally normal heart. Laboratory tests were significant for an unconjugated hyperbilirubinemia of 17 mg/dl, normal electrolytes, a creatinine of 1.1 mg/dl, hematocrit of 44% (normal 42-60%), reticulocyte count of 5.5% (normal 3-7%), and platelet count of 9Â10 9 /l (normal 135-465Â10 9 /l). Examination of the peripheral smear was significant for the presence of red blood cell fragments.
Phototherapy was started, antibiotics were continued, and a platelet transfusion (15 ml/kg) was given in preparation for a This report describes a newborn who presented with hyperbilirubinemia and thrombocytopenia. The patient recovered after treatment with antibiotics, phototherapy, and a platelet transfusion. Analysis of the plasma von Willebrand factor -cleaving metalloprotease, ADAMTS13, revealed low protease activity in the patient and her two siblings, and a mild deficiency in both parents. These results confirmed the clinical suspicion of hereditary thrombotic thrombocytopenic purpura ( TTP ). Although most cases of thrombocytopenia and hyperbilirubinemia in the newborn period are caused by other causes, genetic deficiency of ADAMTS13 may not be as uncommon as previously believed. Early diagnosis may have important implications for the patients. 
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double volume exchange transfusion. After the platelet transfusion, the level of unconjugated bilirubin dramatically decreased and normalized over the next few days. Because of the improvement, the exchange transfusion was never performed. The posttransfusion platelet count was 346Â10 9 /l and never fell below 180Â10 9 /l. Oral intake, which was poor before transfusion, also improved. Blood and urine cultures were negative and antibiotics were stopped after 72 hours. During the hospitalization, the serum creatinine rose to a peak of 1.7 mg/ml, but returned to normal by the time of discharge on day of life (DOL) 8.
Analysis of a plasma sample obtained on DOL 4 showed the ADAMTS13 level 8 at 10% of normal activity (normal range of our laboratory is 79-127%). When the patient was 4 months old, she, her parents, and her siblings were evaluated. At this time, all family members were in good health. The levels of ADAMTS13 activity are shown in Figure 1 . All three children had significantly decreased ADAMTS13 activity, while the parents were only partially deficient. In mixing studies as previously described, 12 inhibitors of the ADAMTS13 activity were not detected. Analysis of the plasma samples by SDS agarose gel electrophoresis 8 revealed the presence of ultra-large multimers in the patient and her siblings, but not in her parents (Figure 2 ).
DISCUSSION
The infant whose case is described here presented with jaundice, low-grade fever, and tachypnea. Laboratory studies were significant for hyperbilirubinemia, thrombocytopenia, hemolysis, and an increased creatinine. These features and the age of onset suggested a potential diagnosis of Upshaw-Schulman syndrome.
1,2 The low ADAMTS13 level present on DOL 4 was confirmed at 4 months of age, and the hereditary nature demonstrated by severe deficiency found in her siblings and partial deficiency detected in her parents. Deficient vWF cleavage was also demonstrated by the presence of ultra-large vWF multimers in all three children, but not the parents.
Several investigators have reported a deficiency of vWF-cleaving protease in patients with the congenital form of the disease. 13 -15 However, the ability to diagnosis ADAMTS13 deficiency in the newborn period is laboratory-dependent. One study reported that vWF-cleaving protease is decreased in normal newborns (25-118% versus 40-179% for normal controls). 16 That study used barium chloride to activate ADAMTS13 and decreased collagen binding as an indirect measure of proteolysis. In contrast, our assay directly detects vWF cleavage by gel electrophoresis, and generates a range of 79% to 127% activity for normal individuals. In our analysis of 17 umbilical cord plasma samples, just one was found to have a low ADAMTS13 level, and it was only minimally decreased at 71% (Han-Mou Tsai, unpublished data). These observations indicate that it is possible to make a diagnosis of ADAMTS13 deficiency soon after birth. Since high levels of shear stress are required for cleavage of vWF by ADAMTS13, 8, 10 the presence of ultra-large vWF multimers found in the blood of fetus, umbilical cords, and normal newborns 17 is probably due to the exceeding low shear stress in the placental circulation.
Our patient has remained in good health since the initial episode. Her two siblings also have not had any problems following similar but less severe events during the neonatal period. The levels of ADAMTS13 activity detected in this pedigree (10-12%) are a bit higher than those in the previously reported TTP cases using the same assay. 5 In serial analysis of patients with the acquired form of TTP, decreased platelet counts are only observed when the ADAMTS13 level falls below 10% (Han-Mou Tsai, personal observation). It appears that the patient and her siblings have a mild form of the disease since they have slightly but critically higher levels of ADAMTS13 activity. I -labeled donkey antirabbit IgG. 8 The migration of IgM is shown as a molecular weight marker. The brackets enclose the ultra -large multimers.
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In acquired TTP, worsening of thrombotic complications has been observed immediately after platelet transfusion. It is postulated that platelet transfusion is detrimental because additional platelets promote intravascular thrombosis. In this case, the thrombocytopenia and hemolysis improved after platelet transfusion. This seemingly unexpected response is due to the absence of inhibitors of ADAMTS13 in our patient. Although it was not measured, the ADAMTS13 activity would be expected to increase above 20% to 25% following the infusion of 15 ml/kg of a nonvolume reduced platelet product. This level is sufficient for clinical remission. Interestingly, the outcome would have been the same if she had received exchange transfusion, the standard therapy for hyperbilirubinemia with hemolysis. Were it not confirmed by analysis of vWF and ADAMTS13, the diagnosis of congenital TTP could have been questioned clinically after she had responded to platelet transfusion.
Congenital TTP is believed to be a rare disease. The identification of three cases in this family suggests that this condition is more frequent than is generally appreciated. Since many of the manifestations of congenital ADAMTS13 deficiency overlap with other conditions, we suggest that this diagnosis should be considered even in neonates who improve without specific therapy. The early diagnosis of hereditary ADAMTS13 deficiency is necessary to adequately monitor the disease. Serious complications such as strokes or renal impairment can occur later, particularly during periods of stressful conditions such as infection, fever, diarrhea, surgery, or pregnancy. Complications are preventable with timely infusion of plasma or ADAMTS13 protein if it becomes available.
